AB
ADMA icon

Amalgamated Bank’s ADMA Biologics ADMA Stock Holding History

Amalgamated Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Sell
62,230
-6,096
-9% -$55.6K ﹤0.01% 1350
2026
Q1 		$616K Sell
68,326
-794
-1% -$12.5K ﹤0.01% 1253
2025
Q4 		$1.26M Buy
69,120
+1,036
+2% +$17.5K 0.01% 985
2025
Q3 		$998K Buy
68,084
+419
+0.6% +$7.18K 0.01% 1062
2025
Q2 		$1.23M Buy
67,665
+540
+0.8% +$11K 0.01% 967
2025
Q1 		$1.33M Sell
67,125
-1,585
-2% -$27.4K 0.01% 926
2024
Q4 		$1.18M Buy
68,710
+541
+0.8% +$10.2K 0.01% 999
2024
Q3 		$1.36M Buy
68,169
+60,620
+803% +$943K 0.01% 948
2024
Q2 		$84K Buy
7,549
+302
+4% +$2.53K ﹤0.01% 1749
2024
Q1 		$48K Sell
7,247
-16,543
-70% -$90.4K ﹤0.01% 1876
2023
Q4 		$108K Sell
23,790
-1,920
-7% -$7.1K ﹤0.01% 1969
2023
Q3 		$92K Hold
25,710
– – ﹤0.01% 2031
2023
Q2 		$95K Buy
25,710
+1,747
+7% +$6.47K ﹤0.01% 2079
2023
Q1 		$79K Sell
23,963
-2,374
-9% -$8.21K ﹤0.01% 2134
2022
Q4 		$102K Hold
26,337
– – ﹤0.01% 2125
2022
Q3 		$64K Buy
26,337
+214
+0.8% +$513 ﹤0.01% 2349
2022
Q2 		$52K Buy
+26,123
New +$51.4K ﹤0.01% 2455

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Amalgamated Bank's ADMA Position: Q2 2026 in Review

Amalgamated Bank reduced its ADMA Biologics (ADMA) stake by 8.9% in Q2 2026, selling an estimated $55.6K and leaving 62,230 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Amalgamated Bank first reported a position in ADMA in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.36M in Q3 2024. 139 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Amalgamated Bank held 62,230 shares of ADMA Biologics worth $521K as of Q2 2026.
  • Amalgamated Bank sold 6,096 ADMA Biologics shares in Q2 2026, an estimated $55.6K.
  • ADMA Biologics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1350 holding.
  • Amalgamated Bank first reported a position in ADMA Biologics in Q2 2022 and has held it in 17 quarters since.
  • Amalgamated Bank's ADMA Biologics position peaked at $1.36M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.